Moreover, the predictive value of the O-6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status—a widely used glioma marker—was refined by HDAC4 expression level, which was significantly related to CIN in our study. This evidence concerns the gene MGMT and central nervous system cancer.